Bisulfite conversion has emerged as a key trend in the global DNA methylation detection technology market, maintaining its position as the gold standard. Its continued prominence can be attributed to its unmatched accuracy and reliability in deciphering DNA methylation patterns, which are crucial for understanding the epigenetic regulation of genes in health and disease. Despite the development of alternative technologies, bisulfite conversion remains indispensable in both research and clinical settings, ensuring that DNA methylation analysis maintains the highest standards of precision.

The healthcare landscape has undergone a remarkable transformation with the emergence of digital biomarkers. Digital biomarkers represent a pivotal shift in how healthcare professionals collect, analyze, and act upon patient data, fundamentally altering how diseases are diagnosed, treated, and monitored.

Biosurfactants are known as surface-active compounds that can be synthesized by a selected number of natural and biobased sources. Biosurfactants are popular for their biodegradability and low eco-toxicity. Besides biodegradability, low toxicity & high production potential, biosurfactants have a high surface and interfacial activity. Biosurfactants are commercially produced from natural sources such as vegetable oil, glycerol and glucose by the addition of a nonpathogenic microorganisms. Biosurfactants are extracted from natural sources and are also expected to be an alternative to petrochemicals.

Biosurfactants are known as surface-active compounds that can be synthesized by a selected number of natural and biobased sources. Biosurfactants are popular for their biodegradability and low eco-toxicity. Besides biodegradability, low toxicity & high production potential, biosurfactants have a high surface and interfacial activity. Biosurfactants are commercially produced from natural sources such as vegetable oil, glycerol and glucose by the addition of a non-pathogenic microorganisms. Biosurfactants are extracted from natural sources and are also expected to be an alternative to petrochemicals.

The biomarkers market (henceforth referred to as the market studied, unless specified otherwise) was estimated to be USD 51,553.80 million in 2023. It is expected to reach USD 87,642.89 million by 2029, registering a CAGR of 9.18% from 2022 to 2027 (henceforth referred to as the forecast period).